Dr. Charles D. Swerdlow, MD

Dr. Swerdlow practices at Camden Surgery Center in Beverly Hills, California.

Dr. Swerdlow's NPI, 1497727309, was assigned on February 3, 2006. Dr. Swerdlow graduated from Harvard Medical School in 1976. Dr. Swerdlow holds California license G34913.

Dr. Swerdlow's primary practice is Camden Surgery Center, at 414 N Camden Dr, Beverly Hills, CA 90210 in Los Angeles County. The practice phone is (310) 859-3991.

Dr. Swerdlow's primary practice is Camden Surgery Center in Beverly Hills, California. Dr. Swerdlow is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cardiovascular Medical Group of Southern California. Dmand AI also links Dr. Swerdlow to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swerdlow practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Swerdlow's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Swerdlow is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Swerdlow is licensed in California.

Dmand AI lists atrial fibrillation and flutter, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Swerdlow treats.

CMS data shows 7,063 Medicare services from Dr. Swerdlow across 46 procedure codes in 2024, for 439 Medicare patients. Medicare paid $294,046 for them. Every service was in an office.

CMS counts 439 Medicare patients who saw Dr. Swerdlow in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swerdlow's median patient age at 78, with 31% women.

In 2024, Dr. Swerdlow wrote 396 Medicare Part D claims for 112 patients. 68% of them were for generic drugs. CMS names the drug for 283 of them, across 13 drugs with 11 or more claims each, at $106,707 in total drug cost. In 2023, CMS named 408 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Swerdlow for performance year 2024, reported as part of a group. Dr. Swerdlow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Swerdlow as offering telehealth. CMS counts 20 procedures of pacemaker insertion or repair by Dr. Swerdlow, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 146 papers to Dr. Swerdlow, published from 2003 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Defibrillators, Implantable, Electrocardiography and Ventricular Fibrillation. Dr. Swerdlow has published most often in Heart Rhythm. Dr. Swerdlow's most frequent co-authors are Kenneth A. Ellenbogen, MD, Robert Kass, MD and Jay W. Mason, MD.

CMS Open Payments shows 528 general payments to Dr. Swerdlow from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Medtronic, Inc. paid the most, $221,440. It also lists 2 research payments totaling $2,344 in 2016.

Dmand AI lists 6 awards for Dr. Swerdlow, most recently America's Top Doctors in 2018.

Dr. Swerdlow graduated from Harvard Medical School in 1976. Dr. Swerdlow is a member of ACC.

Dr. Swerdlow is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.